Carmignac Gestion purchased a new stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 44,475 shares of the company’s stock, valued at approximately $5,903,000. Other hedge funds and other institutional investors also recently modified […]